I am a
Home I AM A Search Login

Papers of the Week

2022 Feb 26

Acta Neurol Scand

Eptinezumab for migraine prevention in patients 50 years or older.


Martin V, Tassorelli C, Ettrup A, Hirman J, Cady R
Acta Neurol Scand. 2022 Feb 26.
PMID: 35218203.


To evaluate the efficacy and safety of eptinezumab versus placebo in patients ≥50 years old with episodic (EM) or chronic migraine (CM).